Abstract
Invasive fungal infections are quite rare (1–5%) following conventional ABMT for malignant lymphoma. Two high-risk lymphoma patients (one non-Hodgkin’s lymphoma (NHL) and one Hodgkin’s disease) underwent ABMT followed by immunotherapy as part of an experimental therapy given to 12 lymphoma patients aiming to prevent relapse following transplantation. The post-immunotherapy course in both patients was complicated by invasive fungal infections (pulmonary mucormycosis and generalized aspergillosis). The association between invasive fungal infection and immunotherapy following ABMT for malignant lymphoma patients is discussed
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Toren, A., Or, R., Ackerstein, A. et al. Invasive fungal infections in lymphoma patients receiving immunotherapy following autologous bone marrow transplantation (ABMT). Bone Marrow Transplant 20, 67–69 (1997). https://doi.org/10.1038/sj.bmt.1700847
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1700847
Keywords
This article is cited by
-
Indolent aspergillus arthritis complicating fludarabine-based non-myeloablative stem cell transplantation
Bone Marrow Transplantation (2001)
-
Allogeneic peripheral blood stem cell transplantation using a fludarabine-based low intensity conditioning regimen for malignant lymphoma
Bone Marrow Transplantation (2000)